A medical startup team affiliated with the University of Connecticut is working to create a faster, safer technique that will aid plastic surgeons in reconstruction while minimizing the risk of complications.
“As scientists, we want to address medical problems with viable solutions that can change people’s lives,’’ says Jacob Quint, a Ph.D. student in the School of Engineering and member of the InPrint Bio company. “It is why we pursued careers in science in the first place.’’
InPrint Bio’s technology is so unique that the team has applied for a “breakthrough” designation from the FDA, which could shave years off its path to market. The startup has already been approached by several companies and biomedical research labs interested in forming a partnership.